haloperidol has been researched along with Cerebral Ischemia in 19 studies
Haloperidol: A phenyl-piperidinyl-butyrophenone that is used primarily to treat SCHIZOPHRENIA and other PSYCHOSES. It is also used in schizoaffective disorder, DELUSIONAL DISORDERS, ballism, and TOURETTE SYNDROME (a drug of choice) and occasionally as adjunctive therapy in INTELLECTUAL DISABILITY and the chorea of HUNTINGTON DISEASE. It is a potent antiemetic and is used in the treatment of intractable HICCUPS. (From AMA Drug Evaluations Annual, 1994, p279)
haloperidol : A compound composed of a central piperidine structure with hydroxy and p-chlorophenyl substituents at position 4 and an N-linked p-fluorobutyrophenone moiety.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Strong concerns have been raised about whether the risk of ischemic stroke differs between risperidone and haloperidol." | 7.81 | A comparison of risperidone and haloperidol for the risk of ischemic stroke in the elderly: a propensity score-matched cohort analysis. ( Choi, NK; Lee, J; Lee, SH; Park, BJ; Park, MJ; Shin, JY, 2015) |
| " Strong concerns have been raised about whether the risk of ischemic stroke differs between risperidone and haloperidol." | 3.81 | A comparison of risperidone and haloperidol for the risk of ischemic stroke in the elderly: a propensity score-matched cohort analysis. ( Choi, NK; Lee, J; Lee, SH; Park, BJ; Park, MJ; Shin, JY, 2015) |
| "Global cerebral ischemia/reperfusion (GCI/R) injury in swiss albino mice was induced by occluding the common carotid arteries for 17 min, followed by 24 h reperfusion." | 1.56 | Possible involvement of D2/D3 receptor activation in ischemic preconditioning mediated protection of the brain. ( Kulkarni, GT; Sharma, B; Sharma, P, 2020) |
| "Haloperidol is an effective antipsychotic agent, but it causes Parkinsonian-like extrapyramidal symptoms in the majority of treated subjects." | 1.43 | A Pharmacogenetic Discovery: Cystamine Protects Against Haloperidol-Induced Toxicity and Ischemic Brain Injury. ( Clark, JD; Dill, DL; Giffard, R; Nishimura, T; Nishimura, Y; Peltz, G; Sahbaie, P; Wu, M; Xiong, X; Xu, D; Xu, LJ; Zhang, H; Zheng, M, 2016) |
| " Piglets subjected to hypoxia followed by asphyxic cardiac arrest were treated with saline or two dosing regimens of PPBP after resuscitation." | 1.36 | Sigma receptor ligand 4-phenyl-1-(4-phenylbutyl)-piperidine modulates neuronal nitric oxide synthase/postsynaptic density-95 coupling mechanisms and protects against neonatal ischemic degeneration of striatal neurons. ( Carter, EL; Koehler, RC; Martin, LJ; Torbey, MT; Yang, ZJ, 2010) |
| "Hemiballismus is characterized by the abrupt onset of violent proximal flinging movements, affecting the limbs, neck and trunk on one side of the body." | 1.32 | Hemiballismus following general anesthesia. A case report. ( Buraczyńska, K; Pilarczyk, M; Sagan, M; Stelmasiak, Z; Tynecka, M, 2003) |
| "When haloperidol 2 mg/kg was administered i." | 1.31 | Dopaminergic neurotransmission triggers ischemia-induced hyperactivity in Mongolian gerbils. ( Araki, H; Futagami, K; Gomita, Y; Kawasaki, H; Yamamoto, T, 2001) |
| "Risperidone was well tolerated despite this adolescent's severe cardiac and pulmonary illnesses." | 1.29 | Use of risperidone in psychotic disorder following ischemic brain damage. ( DeMaso, DR; Steingard, RJ; Zimnitzky, BM, 1996) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (15.79) | 18.7374 |
| 1990's | 6 (31.58) | 18.2507 |
| 2000's | 5 (26.32) | 29.6817 |
| 2010's | 4 (21.05) | 24.3611 |
| 2020's | 1 (5.26) | 2.80 |
| Authors | Studies |
|---|---|
| Sharma, P | 1 |
| Kulkarni, GT | 1 |
| Sharma, B | 1 |
| Shin, JY | 1 |
| Choi, NK | 1 |
| Lee, J | 1 |
| Park, MJ | 1 |
| Lee, SH | 1 |
| Park, BJ | 1 |
| Zhang, H | 1 |
| Zheng, M | 1 |
| Wu, M | 1 |
| Xu, D | 1 |
| Nishimura, T | 1 |
| Nishimura, Y | 1 |
| Giffard, R | 1 |
| Xiong, X | 1 |
| Xu, LJ | 1 |
| Clark, JD | 1 |
| Sahbaie, P | 1 |
| Dill, DL | 1 |
| Peltz, G | 1 |
| Rajput, SK | 1 |
| Sharma, AK | 1 |
| Meena, CL | 1 |
| Pant, AB | 1 |
| Jain, R | 1 |
| Sharma, SS | 1 |
| Yang, ZJ | 1 |
| Carter, EL | 1 |
| Torbey, MT | 1 |
| Martin, LJ | 1 |
| Koehler, RC | 2 |
| Goyagi, T | 2 |
| Bhardwaj, A | 4 |
| Traystman, RJ | 3 |
| Hurn, PD | 3 |
| Kirsch, JR | 4 |
| Pilarczyk, M | 1 |
| Buraczyńska, K | 1 |
| Sagan, M | 1 |
| Tynecka, M | 1 |
| Stelmasiak, Z | 1 |
| Okajima, Y | 1 |
| Nishi, K | 1 |
| Busch, KT | 1 |
| Schulz, H | 1 |
| Wishart, TB | 1 |
| Ijaz, S | 1 |
| Shuaib, A | 1 |
| Dragunow, M | 1 |
| Young, D | 1 |
| Hughes, P | 1 |
| MacGibbon, G | 1 |
| Lawlor, P | 1 |
| Singleton, K | 1 |
| Sirimanne, E | 1 |
| Beilharz, E | 1 |
| Gluckman, P | 1 |
| Zimnitzky, BM | 1 |
| DeMaso, DR | 1 |
| Steingard, RJ | 1 |
| Vila, N | 1 |
| Chamorro, A | 1 |
| O'Neill, MJ | 1 |
| Hicks, CA | 1 |
| Ward, MA | 1 |
| Cardwell, GP | 1 |
| Reymann, JM | 1 |
| Allain, H | 1 |
| Bentué-Ferrer, D | 1 |
| Harukuni, I | 2 |
| Crain, B | 1 |
| London, ED | 2 |
| Shaivitz, AB | 1 |
| DeVries, AC | 1 |
| Faraci, FM | 1 |
| Goto, S | 1 |
| Dawson, VL | 1 |
| Yamamoto, T | 1 |
| Araki, H | 1 |
| Futagami, K | 1 |
| Kawasaki, H | 1 |
| Gomita, Y | 1 |
| Ahlemeyer, B | 1 |
| Krieglstein, J | 1 |
19 other studies available for haloperidol and Cerebral Ischemia
| Article | Year |
|---|---|
Possible involvement of D2/D3 receptor activation in ischemic preconditioning mediated protection of the brain.
Topics: Animals; Brain Ischemia; Cytokines; Dopamine Antagonists; Haloperidol; Ischemic Preconditioning; Mal | 2020 |
A comparison of risperidone and haloperidol for the risk of ischemic stroke in the elderly: a propensity score-matched cohort analysis.
Topics: Aged; Aged, 80 and over; Antipsychotic Agents; Brain Ischemia; Cohort Studies; Female; Haloperidol; | 2015 |
A Pharmacogenetic Discovery: Cystamine Protects Against Haloperidol-Induced Toxicity and Ischemic Brain Injury.
Topics: Amidohydrolases; Animals; Antipsychotic Agents; Brain Ischemia; Cell Adhesion Molecules; Cystamine; | 2016 |
Effect of L-pGlu-(1-benzyl)-l-His-l-Pro-NH
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Brain Ischemia; Catalepsy; Cell Death; Diseas | 2016 |
Sigma receptor ligand 4-phenyl-1-(4-phenylbutyl)-piperidine modulates neuronal nitric oxide synthase/postsynaptic density-95 coupling mechanisms and protects against neonatal ischemic degeneration of striatal neurons.
Topics: Analysis of Variance; Animals; Animals, Newborn; Brain Ischemia; Corpus Striatum; Disease Models, An | 2010 |
Potent sigma 1-receptor ligand 4-phenyl-1-(4-phenylbutyl) piperidine provides ischemic neuroprotection without altering dopamine accumulation in vivo in rats.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Blood Gas Analysis; Body Temperature; Brain Chemistry; Brai | 2003 |
Hemiballismus following general anesthesia. A case report.
Topics: Anesthesia, General; Anticonvulsants; Antipsychotic Agents; Brain Ischemia; Clonazepam; Dyskinesias; | 2003 |
Analysis of inhibitory and excitatory actions of dopamine on chemoreceptor discharges of carotid body of cat in vivo.
Topics: Animals; Brain Ischemia; Carotid Body; Cats; Chemoreceptor Cells; Dopamine; Electrophysiology; Halop | 1981 |
[The acute psychiatric emergency].
Topics: Acute Disease; Aged; Alcoholism; Amitriptyline; Brain Ischemia; Cognition Disorders; Consciousness D | 1981 |
Differential effects of amphetamine and haloperidol on recovery after global forebrain ischemia.
Topics: Animals; Brain Ischemia; Dextroamphetamine; Disease Models, Animal; Gerbillinae; Haloperidol; Male; | 1994 |
Is c-Jun involved in nerve cell death following status epilepticus and hypoxic-ischaemic brain injury?
Topics: Animals; Apoptosis; Brain Ischemia; Dizocilpine Maleate; Genes, fos; Genes, jun; Haloperidol; Hypoxi | 1993 |
Use of risperidone in psychotic disorder following ischemic brain damage.
Topics: Adult; Brain Ischemia; Haloperidol; Humans; Male; Perphenazine; Psychotic Disorders; Risperidone | 1996 |
Ballistic movements due to ischemic infarcts after intravenous heroin overdose: report of two cases.
Topics: Adult; Anti-Dyskinesia Agents; Basal Ganglia; Brain Ischemia; Coma; Corpus Striatum; Drug Overdose; | 1997 |
Dopamine D2 receptor agonists protect against ischaemia-induced hippocampal neurodegeneration in global cerebral ischaemia.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Benzazepines; Brain Ischemia; B | 1998 |
Neuroprotection from focal ischemia by 4-phenyl-1-(4-phenylbutyl) piperidine (PPBP) is dependent on treatment duration in rats.
Topics: Animals; Brain Ischemia; Cerebral Infarction; Haloperidol; Infusions, Intravenous; Male; Neuroprotec | 1998 |
sigma(1)-receptor ligand 4-phenyl-1-(4-phenylbutyl)-piperidine affords neuroprotection from focal ischemia with prolonged reperfusion.
Topics: Animals; Behavior, Animal; Brain Ischemia; Cerebral Infarction; Drug Administration Schedule; Halope | 2000 |
Neuroprotective effect of sigma(1)-receptor ligand 4-phenyl-1-(4-phenylbutyl) piperidine (PPBP) is linked to reduced neuronal nitric oxide production.
Topics: Animals; Brain; Brain Ischemia; Citrulline; Enzyme Inhibitors; Haloperidol; Indazoles; Infarction, M | 2001 |
Dopaminergic neurotransmission triggers ischemia-induced hyperactivity in Mongolian gerbils.
Topics: Animals; Brain Ischemia; Dopamine; Dopamine Antagonists; Gerbillinae; Haloperidol; Hyperkinesis; Inj | 2001 |
Testing drug effects against hypoxic damage of cultured neurons during long-term recovery.
Topics: Adenosine Triphosphate; Animals; Anticonvulsants; Brain Ischemia; Cell Count; Cell Survival; Cells, | 1989 |